[1] 曾学军,张昀.协和全科医师手册[M].北京:中国协和医科大学出版社,2019:655. [2] 杨幸. 脱产备考生心理控制感与其抑郁变化轨迹的关系[D].青海:青海师范大学,2022. [3] 郝伟,陆林.精神病学[M].8版.北京:人民卫生出版社,2018:105. [4] American Psychiatric Association.Diagnostic and statistical manual of mental disorders[M].5th ed.Washington DC:American Psychiatric Association Publishing,2013. [5] 李凌江,马辛.中国抑郁障碍防治指南[M].北京:中华医学电子音像出版社,2015:2. [6] HUANG Y Q,WANG Y,WANG H,et al.Prevalence of mental disorders in China:A cross-sectional epidemiological study[J].The Lancet Psychiatry,2019,3(6):211-224. [7] REIBLING N,BECKFIELD J,HUIJTS T,et al.Depressed during the depression:Has the economic crisis affected mental health inequalities in Europe? Findings from the European Social Survey(2014) special module on the determinants of health[J].Eur J Public Health,2017, 27(suppl_1):47-54. [8] GREENBERG P E,FOURNIER A A,SISITSKY T,et al.The economic burden of adults with major depressive disorder in the United States (2005 and 2010)[J].J Clin Psychiatry,2015,76(2):155-162. [9] 唐启盛. 抑郁障碍中西医研究进展述评[J].北京中医药大学学报,2022,45(9):871-877. [10] 刘宁,吴美平,陈婷,等.国家自然科学基金中医学领域项目2018年度申请与资助情况评述[J].中医杂志,2019,60(6):482-484,508. [11] 曹传东,黄玉凤,韦艳艳,等.中医科研的思路与方法探讨——基于2017年医学类国家自然科学基金项目分析[J].医学与哲学,2019, 40(14):69-72. [12] 肖志鸿,杨爽,刘流,等.国家自然科学基金资助的医学院校中医药学科研竞争力分析[J].中华医学图书情报杂志,2021,30(7):24-30. [13] 张志雄,周乐.生理学[M].3版.上海:上海科学技术出版社,2017:243. [14] VITUREIRA N,DE P R,LEÃO R M,et al.Editorial:Cellular and molecular mechanisms of synaptic plasticity at hippocampal and cortical synapses[J].Front Cell Neurosci,2022,16:980623. [15] REN F,GUO R.Synaptic microenvironment in depressive disorder:Insights from synaptic plasticity[J].Neuropsychiatr Dis Treat,2021,17:157-165. [16] ZANOS P,GOULD T D.Mechanisms of ketamine action as an antidepressant[J].Mol Psychiatry,2018,23:801-811. [17] KRZYSTYNIAK A,BACZYNSKA E,MAGNOWSKA M,et al.Prophylactic ketamine treatment promotes resilience to chronic stress and accelerates recovery:Correlation with changes in synaptic plasticity in the CA3 subregion of the hippocampus[J].Int J Mol Sci,2019,20:1726. [18] YAO N,SKITEVA O,ZHANG X,et al.Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit[J].Mol Psychiatry,2018,23(10):2066-2077. [19] 王广燕,刘小艳,于党波,等.抑郁症神经环路研究进展[J].医学综述,2022,28(13):2630-2634. [20] GORDANA N E,MARINA S,MATEA N P,et al.Depression:Biological markers and treatment[J].Prog Neuropsychopharmacol Biol Psychiatry,2021,105:110139. [21] DEO R C.Machine learning in medicine[J].Circulation,2015,132(20):1920-1930. [22] 廖华龙,曾小茜,李华凤,等.机器学习在疾病预测中的应用[J].生物医学工程研究,2021,40(2):203-209. [23] KOMATSU H,WATANABE E,FUKUCHI M.Psychiatric neural networks and precision therapeutics by machine learning[J].Biomedicines,2021,9(4):403. [24] PRUNESKI J A,WILLIAMS R J,NWACHUKWU B U,et al.The development and deployment of machine learning models[J].Knee Surg Sports Traumatol Arthrosc,2022,30(12):3917-3923. [25] QASEEM A,BARRY M J,KANSAGARA D.Clinical guidelines committee of the american college of physicians.Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder:A clinical practice guideline from the American College of Physicians[J].Ann Intern Med,2016,164(5):350-359. [26] RAVINDRAN A V,BALNEAVES L G,FAULKNER G,et al.Canadian Network for Mood and Anxiety Treatments(CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder:Section 5.Complementary and alternative medicine treatments[J].Focus (Am Psychiatr Publ),2018,16(1):85-94. [27] 张东淑,黄凤,何伟明,等.“十二五”期间国家自然科学基金针灸学领域项目情况回顾与分析[J].中医杂志,2017,58(4):271-275. [28] KC D,SUMNER R,LIPPMANN S.Gut microbiota and health[J].Postgrad Med,2020,132(3):274. [29] VENDRIK K E W,OOIJEVAAR R E,DE JONG P R C,et al.Fecal microbiota transplantation in neurological disorders[J].Front Cell Infect Microbiol,2020,10:98. [30] CAPUCO A,URITS I,HASOON J,et al.Gut microbiome dysbiosis and depression:A comprehensive review[J].Curr Pain Headache Rep,2020, 24(7):36. [31] 汤倩倩,曹丽华.肠道菌群与神经系统疾病[J].生物工程学报,2021, 37(11):3757-3780. [32] RATHOUR D,SHAH S,KHAN S,et al.Role of gut microbiota in depression:Understanding molecular pathways,recent research,and future direction[J].Behav Brain Res,2023,436:114081. [33] SHADRINA M,BONDARENKO E A,SLOMINSKY P A.Genetics factors in major depression disease[J].Front Psychiatry,2018,9:334. [34] UCHIDA S,YAMAGATA H,SEKI T,et al.Epigenetic mechanisms of major depression:Targeting neuronal plasticity[J].Psychiatry Clin Neurosci,2018,72(4):212-227. [35] ALSHAYA D S.Genetic and epigenetic factors associated with depression:An updated overview[J].Saudi J Biol Sci,2022,29(8):103311. [36] APPELBAUM L G,SHENASA M A,STOLZ L,et al.Synaptic plasticity and mental health:Methods,challenges and opportunities[J].Neuropsychopharmacol,2023,48(1):113-120. [37] BLUMBERGER D M,VILA-RODRIGUEZ F,THORPE K E,et al.Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression(THREE-D):A randomised non-inferiority trial[J].Lancet,2018,391(10131):1683-1692. |